Vivani Medical Inc
NASDAQ:VANI
Relative Value
The Relative Value of one
VANI
stock under the Base Case scenario is
0.01
USD.
Compared to the current market price of 1.3 USD,
Vivani Medical Inc
is
Overvalued by 99%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
VANI Competitors Multiples
Vivani Medical Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Vivani Medical Inc
NASDAQ:VANI
|
105.6m USD | 0 | -3.6 | -3.8 | -3.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
194B USD | 4.4 | 29.9 | 16.9 | 23.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
177.7B USD | 17.7 | 62.4 | 47.5 | 58.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
143.8B USD | 5.7 | 44.5 | 22.5 | 27.2 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
124.5B USD | 3.5 | 27 | 14.6 | 21.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.9B USD | 5.5 | 38.1 | 22.7 | 30.4 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.2B EUR | 2 | 22.4 | 12.4 | 17.4 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
52.4B USD | 2.4 | 29.9 | 11.4 | 19.2 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.4B USD | 11.8 | 47.9 | 34.2 | 37.7 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.8B USD | 7.6 | 43.1 | 23.9 | 26.1 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.4B USD | 1.9 | 18.4 | 13 | 15.7 |